The expanding use of advanced preparatory methods and distinct genomic compositions in food is rapidly creating a new age of consumer choices. Simultaneously, these innovative food and ingredient choices are dramatically altering the decisions being made by stakeholders throughout the food supply system, domestically and internationally. Scientific, farming, processing, manufacturing, marketing, and retail distribution communities focused on providing commercially viable products are directly affected, as are government regulators overseeing the safety of the food system and public advocates committed to accurately informing consumers.
The Innovative Foods and Ingredients (IFI) conference series, organized and convened by the ISGP with support from the U.S. Food and Drug Administration (FDA), is part of the ISGP Food Innovation Program. The initial IFI conference in this multi-year project is scheduled to be convened June 23-27, 2019, in Minneapolis, Minnesota.
As a not-for-profit, 501(c)(3), non-partisan organization, the ISGP does not lobby on any issue. The IFI conference series seeks to identify the opportunities, challenges, and priorities recognized by major scientific, technological, private sector, governmental, and public advocacy stakeholders involved in the emergence of innovative foods and ingredients. The first of these IFI conferences focuses on plant- and microbial-derived foods and ingredients and specifically, excludes consideration of food and ingredients derived from cultured mammalian cells or genetically engineered animals.
To promote the candid exchange of ideas and clarity of priorities, the initial, invitation-only IFI conference is convened in a not-for-attribution environment defined by the Chatham House Rule. The critical debate/extended caucus format pioneered by the ISGP over more than a decade has proven to be effective in addressing the diverse, often conflicting, views held by stakeholders from widely different communities such as those found in the food supply system. The IFI conference agenda links options based on evidence-based, credible scientific understanding with commercially realistic decisions concerning how plant- and microbial-derived foods and ingredients can be safely offered to the public under FDA’s statutory frameworks. Recent history surrounding how technology appears in the food supply system emphasizes the need to balance private sector priorities with regulatory structures and narratives used to accurately, and transparently, inform the public about new food choices.
IFI Conference Structure
The initial two days of the IFI conference, June, 24 and 25, are devoted to 90-minute, moderated debates of eight, concise position papers prepared and defended by internationally recognized subject-matter experts. The 60-70 debaters examine and critique the current realities, opportunities, challenges, and priorities identified by all stakeholders. On the third day, June 26, small-group, moderated caucuses attended by all of the approximately 120 participants are held to identify future options and opportunities consistent with stakeholder priorities. A plenary session reviewing the results emerging from the small-group caucuses is held on the final conference morning, June 27. Caucus outcomes, position papers, and not-for-attribution summaries of all debates are prepared and published by the ISGP for free public distribution.
Event Location: Hilton Minneapolis/St. Paul Airport
3800 American Boulevard East, Bloomington, MN 55426
The negotiated rate for the room is the government per diem rate of $151
To reserve your room please visiti:
Additional Conference Details
- Dinners and lunches throughout the conference are included
- The hotel provides a free airport shuttle
- Free wifi
- Free parking
Point of Contact at ISGP
To learn more about the ISGP conference and for more information about how invitations to the conference are being extended.
- Jennifer Boice- email@example.com 520.343.8181
- Nicole Bice- firstname.lastname@example.org 704.682.3052